Post-earnings recap
Reported
Thu, Aug 6, 2026
EPS actual
$0.98
EPS est.
$0.89
EPS surprise
+10.11%
1-day move
+2.74%
Prestige Consumer Healthcare Inc. reported an EPS of $0.98, exceeding expectations by over 10%. The stock reacted positively, rising by 2.74%. However, there was no revenue data provided, and no guidance updates were given, leaving some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.98 | N/A | +10.11% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on over-the-counter pharmaceuticals and consumer health products. With a market cap of $2 billion, the company plays a significant role in the health care industry, particularly as consumer spending on health products continues to grow.
Last quarter
In Q4-2026, Prestige reported an EPS of $1.23, which was below analysts' expectations of $1.39, resulting in an 11.7% surprise. The stock reacted positively, gaining 2.78% the following day despite the earnings miss.
EPS beat streak
1Q
EPS beat rate
63%
Avg EPS surprise
+0.71%
Avg 1-day reaction
+2.58%
Analysts are cautiously optimistic about Prestige's upcoming earnings, given the mixed performance in previous quarters. Investors are particularly focused on whether the company can improve its EPS and revenue figures.
Bull case
If Prestige can exceed EPS expectations and show strong revenue growth, it may signal a turnaround in performance, leading to increased investor confidence.
Bear case
Conversely, if the company continues to miss EPS estimates and fails to demonstrate significant revenue growth, it could lead to further declines in stock price and investor sentiment.
The print will turn on these.
Q1
What will be the EPS for Q1-2027?
EPS is a critical measure of profitability, and a significant deviation from expectations could greatly impact stock performance.
Q2
How is Prestige addressing market competition in the OTC space?
Understanding the company's strategy to maintain or grow its market share will be crucial for assessing its future growth potential.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±10.1%
Why consensus could be wrong
The Street may be underestimating the potential for a rebound in EPS, given recent consumer trends favoring health products.
Supporting evidence
The options market is pricing a 12.18% move, suggesting significant expectations for volatility that may not align with historical performance.
Prestige has a history of surprising on the upside, with a 63% EPS beat rate over the last eight quarters.
Key risk
If the EPS comes in above $1.40, it could shift the narrative significantly.
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as it follows a trend of mixed results, and investors are looking for signs of a sustainable turnaround.
Bull confirmed if
An EPS of $1.40 or higher would confirm the bull case, indicating strong profitability.
Bear confirmed if
An EPS below $1.10 would confirm the bear case, suggesting ongoing struggles in profitability.
What the market is pricing for the move.
Implied Move
±12.18%
Historical Avg
±5.6%
The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.
Options are pricing ±12.2% while PBH has averaged ±5.6% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
45.3%
Cross-company pattern from 30 similar setups.
Prior-quarter miss + options pricing rich setup in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.8%, with a raw directional average of -1.6% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
116.58%
of float
Insider
1.41%
of float
Holders
435
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
7,831,333 sh · $372.5M
16.53%
6.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Prestige beats expectations, history suggests a potential average stock move of +5.17%, confirming a positive outlook.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors digest the commentary.
Miss
A miss could lead to a decline, with historical patterns indicating an average drop of -3.16% following earnings misses.
The lines on the call that would change the story.
Ariel Investments, LLC
4,868,711 sh · $231.6M
10.28%
13.9%
Vanguard Portfolio Management LLC
2,825,340 sh · $134.4M
5.96%
0.8%
Dimensional Fund Advisors LP
2,661,291 sh · $126.6M
5.62%
-0.4%
Fuller & Thaler Asset Management Inc.
2,331,821 sh · $110.9M
4.92%
100.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.